BiotechTube
Home/BioXcel Therapeutics/Vimal Mehta, Ph.D.
VM

Vimal Mehta, Ph.D.

Founder and Chief Executive Officer

BioXcel Therapeutics

Therapeutic Areas

NeuroscienceImmuno-Oncology

BioXcel Therapeutics Pipeline

DrugIndicationPhase
IGALMI (BXCL501)Acute agitation (schizophrenia/bipolar) - At-home usesNDA Review
BXCL501Opioid WithdrawalPhase 2
BXCL701Advanced Prostate Cancer (combo)Phase 2